Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-000600

Options or other derivatives

  • PRESIDENT AND CEO acquired 700,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chacko Jacob PRESIDENT AND CEO 2025-01-02 Grant or award · Stock Option (right to buy) +600,000 600,000 D
Chacko Jacob PRESIDENT AND CEO 2025-01-02 Grant or award · Restricted Stock Unit +100,000 100,000 D
Loading xslF345X05/form4-01032025_100156.xml…